1. Absolute benefit from adjuvant chemotherapy in contemporary clinical trials: A systemic review and meta-analysis. (December 2018) Authors: Goldvaser, Hadar; Ribnikar, Domen; Majeed, Habeeb; Ocaña, Alberto; Amir, Eitan Journal: Cancer treatment reviews Issue: Volume 71(2018) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Associations between safety, tolerability, and toxicity and the reporting of health‐related quality of life in phase III randomized trials in common solid tumors. (4th September 2020) Authors: Saleh, Ramy R.; Meti, Nicholas; Ribnikar, Domen; Goldvaser, Hadar; Ocana, Alberto; Templeton, Arnoud J.; Seruga, Bostjan; Amir, Eitan Journal: Cancer medicine Issue: Volume 9:Number 21(2020) Page Start: 7888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Concordance between the results of randomized and non-randomized interventional clinical trials assessing the efficacy of drugs for COVID-19: a cross-sectional study. (2nd June 2021) Authors: Shepshelovich, Daniel; Yahav, Dafna; Ben Ami, Ronen; Goldvaser, Hadar; Tau, Noam Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 9(2021) Page Start: 2415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of extended adjuvant therapy with aromatase inhibitors in early breast cancer among common clinicopathologically-defined subgroups: A systematic review and meta-analysis. (November 2017) Authors: Goldvaser, Hadar; AlGorashi, Ibrahim; Ribnikar, Domen; Seruga, Bostjan; Templeton, Arnoud J.; Ocana, Alberto; Amir, Eitan Journal: Cancer treatment reviews Issue: Volume 60(2017) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis. (1st September 2020) Authors: Kundel, Yulia; Sternschuss, Michal; Moore, Assaf; Perl, Gali; Brenner, Baruch; Goldvaser, Hadar Journal: Cancer medicine Issue: Volume 9:Number 20(2020) Page Start: 7613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis. (1st September 2020) Authors: Kundel, Yulia; Sternschuss, Michal; Moore, Assaf; Perl, Gali; Brenner, Baruch; Goldvaser, Hadar Journal: Cancer medicine Issue: Volume 9:Number 20(2020) Page Start: 7613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evolution in sites of recurrence over time in breast cancer patients treated with adjuvant endocrine therapy. (November 2018) Authors: Algorashi, Ibrahim; Goldvaser, Hadar; Ribnikar, Domen; Cescon, David W.; Amir, Eitan Journal: Cancer treatment reviews Issue: Volume 70(2018) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fractionation scheme and treatment planning method for early glottic cancer in the United States: Economic impact of different medical decisions. Issue 8 (24th January 2020) Authors: Moore, Assaf; Den, Robert B.; Popovtzer, Aaron; Goldvaser, Hadar; Gordon, Noa; Goldstein, Daniel A. Journal: Head & neck Issue: Volume 42:Issue 8(2020) Page Start: 1713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers. Issue 14 (10th May 2022) Authors: Lieberman, Sari; Goldvaser, Hadar; Levy-Lahad, Ephrat Journal: Journal of clinical oncology Issue: Volume 40:Issue 14(2022) Page Start: 1590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer. (September 2017) Authors: Goldvaser, Hadar; Ribnikar, Domen; Fazelzad, Rouhi; Seruga, Bostjan; Templeton, Arnoud J.; Ocana, Alberto; Amir, Eitan Journal: Cancer treatment reviews Issue: Volume 59(2017) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗